论文部分内容阅读
目的探讨美托洛尔对扩张性心肌病患者的疗效。方法选取2014年5月~2016年2月我院收治的扩张性心肌病患者237例作为研究对象,将其随机分为观察组119例和对照组118例。对照组采取常规治疗方案,观察组在此基础上采取美托洛尔治疗方案。比较两组的疗效,心功能改善状况和预后情况。结果观察组总有效率为98.32%明显高于对照组的79.66%,心肌功能异常率较对照组低,良好预后率较对照组高,差异均有统计学意义(P<0.05)。结论美托洛尔对扩张性心肌病患者的疗效显著,有助于良好预后,值得推广。
Objective To investigate the effect of metoprolol on patients with dilated cardiomyopathy. Methods A total of 237 patients with dilated cardiomyopathy treated in our hospital from May 2014 to February 2016 were selected as study subjects and randomly divided into observation group (119 cases) and control group (118 cases). The control group to take conventional treatment programs, the observation group on this basis to take metoprolol treatment. The curative effect, heart function improvement and prognosis of the two groups were compared. Results The total effective rate of observation group was 98.32%, which was significantly higher than 79.66% of control group. The rate of myocardial dysfunction was lower than that of control group. The good prognosis rate was higher than that of control group (P <0.05). Conclusion Metoprolol is effective in patients with dilated cardiomyopathy and is good for prognosis. It is worth popularizing.